Precision medicine in chronic disease management: The multiple sclerosis BioScreen.
Ann Neurol
; 76(5): 633-42, 2014 Nov.
Article
en En
| MEDLINE
| ID: mdl-25263997
ABSTRACT
We present a precision medicine application developed for multiple sclerosis (MS) the MS BioScreen. This new tool addresses the challenges of dynamic management of a complex chronic disease; the interaction of clinicians and patients with such a tool illustrates the extent to which translational digital medicine-that is, the application of information technology to medicine-has the potential to radically transform medical practice. We introduce 3 key evolutionary phases in displaying data to health care providers, patients, and researchers visualization (accessing data), contextualization (understanding the data), and actionable interpretation (real-time use of the data to assist decision making). Together, these form the stepping stones that are expected to accelerate standardization of data across platforms, promote evidence-based medicine, support shared decision making, and ultimately lead to improved outcomes.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Manejo de la Enfermedad
/
Teoría de la Información
/
Esclerosis Múltiple
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Ann Neurol
Año:
2014
Tipo del documento:
Article
País de afiliación:
Canadá